New Rochelle, NY, May 7, 2019—Cannabis and Cannabinoid Research (CCR) is extremely excited to announce that the International Cannabinoid Research Society (ICRS) has named CCR its Official Journal. The ICRS is a foremost international society spearheading scientific research in all fields of cannabinoids, ranging from biochemical, chemical, and physiological studiesRead
Recently, Biotics Research became the first professional supplement brand in the United States to join the ranks of GOED membership. Formed in 2007, GOED, the Global Organization of EPA and DHA Omega-3s, is comprised of a number of entities in the omega-3s industry, from fish oil producers to those manufacturingRead
Statement from FDA Commissioner Scott Gottlieb, M.D., on new steps to advance agency’s continued evaluation of potential regulatory pathways for cannabis-containing and cannabis-derived products In recent years, we’ve seen a growing interest in the development of therapies and other FDA-regulated consumer products derived from cannabis (Cannabis sativa L.) and itsRead
Capitol Hill Legislators and Staffers Get a Hands-On Introduction to Integrative Medicine WASHINGTON DC – On March 6, 2019, the second annual Congressional Integrative Health and Wellness Caucus, co-led by Rep. Judy Chu (D-CA), and Rep. Jackie Walorski (R-IN), was held for an audience of 50 Democratic and Republican HouseRead
The White House recently announced its intention to appoint Dr. Ned Sharpless, current director of the National Cancer Institute (NCI), as acting commissioner of the Food and Drug Administration (FDA). Dr. Doug Lowy, current deputy director at NCI, will take over as acting director. “Dr. Sharpless has demonstrated extraordinary leadershipRead
In a surprise announcement, Food and Drug Commissioner Scott Gottlieb MD announced his planned resignation this week, to go into effect in April. Gottlieb became known for his tough stance on tobacco and e-cigarettes and for tackling previously untouched issues like drug prices, the opioid crisis and even recognizing theRead
The following is an excerpt of interview with Paul Anderson, ND on the FDA’s recent stance on compounded medicine as published in the Journal of Restorative Medicine, Volume 8, Number 1, 4 January 2019, pp. 1-5(5). The Journal of Restorative Medicine (JRM) recently interviewed Paul Anderson, ND, who is testifyingRead
Lenexa, KS, January 29, 2019 – After thirty years as the nation’s leading voice for integrative pain management, the Academy of Integrative Pain Management (AIPM) will cease operations and solicit members’ permission to dissolve as an organization in the coming weeks. AIPM’s Board of Directors voted unanimously on January 26Read
WASHINGTON, D.C., January 29, 2019– The bipartisan Congressional Integrative Health and Wellness Caucus has been registered with two new co-chairs at the helm for the 116th Congress. Representative Judy Chu (CA-21st) will serve as the Democratic leader with Representative Jackie Walorski (IN-2nd) as the Republican leader, replacing former Caucus co-chairsRead
Want your voice heard about integrative pain management? The Pain Management Best Practices Interagency Task Force issued its draft report in late Dec. 2018. The comment period is open for the next 90 days, until March 28, 2019. The Pain Management Best Practices Inter-Agency Task Force (Task Force), in aRead
